COLL Stock Ownership Activity

COLLEGIUM PHARMACEUTICAL INC 13F holders

1 value investing guru has made changes to the COLLEGIUM PHARMACEUTICAL INC (COLL) position according to the gurus' latest SEC quarterly report(s). The number of COLL shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying COLL now?

According to the latest SEC filing(s) COLLEGIUM PHARMACEUTICAL INC (COLL) has been bought by Marty Whitman - Third Avenue Management (added shares +0.2%).

To see more about who is investing in COLLEGIUM PHARMACEUTICAL INC (COLL), please go to the COLL ownership page.

2024 Q3 (1 result)
Marty Whitman
+0.20%
+370
+0.00%
1.15%
Current price: $29.58 23.45% Reported price*: $38.64
2024 Q2 (1 result)
Marty Whitman
+68.59%
+74,161
+0.41%
1.01%
Current price: $29.58 8.14% Reported price*: $32.20
2024 Q1 (1 result)
Marty Whitman
+30.08%
+25,000
+0.15%
0.67%
Current price: $29.58 23.80% Reported price*: $38.82
2023 Q4 (1 result)
Marty Whitman
buy
+83,120
+0.42%
0.42%
Current price: $29.58 3.90% Reported price*: $30.78
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.